Projects & Research
- National Alcohol and Drug Knowledgebase (NADK)
- National Pharmaceutical Drug Misuse Strategy
- Young Australians Alcohol Reporting System (YAARS)
National Alcohol and Drug Knowledgebase (NADK)
Start Date: Not specified
End Date: Not specified
Contact Person: Professor Ann Roche
Primary Funder: Australian Government Department of Health and Ageing
Aim: The National Alcohol Knowledgebase (NAK) Project has three main objectives.
1. Design and construct a document that works effectively in electronic and hard copy versions that will act as a public reference and dissemination vehicle for alcohol-related information.
2. Develop nationally agreed standards and procedures for deriving statistics and parameters, and reporting on data relating to alcohol consumption, harms, treatment, and sales.
3. Derive information relating to alcohol consumption, harms, treatment, and sales using the new data standards and procedures.
Method: The development of the template will involve the following steps -
> Identify relevant datasets through a search and consultation process
> select relevant datasets by applying criteria for quality, accessibility and utility
> Summarise features of selected datasets by describing key characteristics
> Design a searchable template prototype
> Establish criteria for indexing dataset features
> Undertake a consultative and review process with key stakeholders
> Modify and finalise the template
> Review and revise (where applicable) after the Data Standards are developed.
The development of standards as outlined here will be informed by existing guidelines for the development of data standards (AIHW, 2007) and the development of indicators of alcohol consumption and related harm (WHO, 2000).
The methodology for this part of the project entails a series of discreet stages. The stages to be undertaken in meeting Aim 2 also overlap and dovetail with some of the stages involved in meeting Aim 1. In this way, a seamless project management plan can be developed and all components of the project executed with maximum efficiency.
Stage 1: Identification and audit of existing datasets (continuation of work undertaken in Part 1)
Stage 2: Review of existing relevant data, analysis and reporting standards
Stage 3: Production of a draft set of standards
Stage 4: Key stakeholder consultation
Stage 5: Revision of draft standards
Stage 6: Production of an alcohol-related data standards report.
Subjecting select data identified in meeting Aim 1 to secondary analyses to derive alcohol-related statistics in accord with the standards developed in meeting Aim 2. In addition, alcohol-related statistics produced as a result of these secondary analyses will be reported in a format consistent with the reporting template developed in meeting Aim 1.
National Pharmaceutical Drug Misuse Strategy
Start Date: 2010
End Date: 2011
Contact Person: Professor Ann Roche
Primary Funder: Victorian Department of Health
Aim: The issue of pharmaceutical misuse has been identified across Australia as an emerging problem of significant concern. Due to the need for a consolidated national response, a National Pharmaceutical Drug Misuse Strategy (NPDMS) is being developed by a consortium led by the National Centre for Education and Training on Addiction (NCETA) at Flinders University.
The Strategy is being developed at the request of the Ministerial Council on Drug Strategy (MCDS) and is being funded through the MCDS Cost Shared Funding Model. The project is being overseen by the Victorian Department of Health.
Method: Development of the Strategy:
The development of the Strategy will involve:
>> a review of existing Australian and international knowledge and research including relevant legislation and regulatory controls/mechanisms
>> a comprehensive national consultation process with key stakeholders in metropolitan and regional Australia, including a number of consultation forums, and
>> written submissions.
Scope of the Strategy:
The Strategy will cover both prescription and over-the-counter drugs. Particular focus will be given to pharmaceutical drugs subject to non-medical use, misuse and/or diversion.
Priority will be given to the drugs that cause the most harm. Responses will be developed in the areas of:
>> supply reduction
>> demand reduction
>> harm reduction.
Responses will aim to balance the need to prevent harm caused by misuse, while continuing to ensure that those who have a medical need can continue to access appropriate medicines. A wide-ranging consultation process is essential to the development of such a balanced strategy.
Discussion Paper & Literature Review
A discussion paper has been developed to inform the Strategy development process. It was informed by the literature review and by discussions with key experts in the area from a variety of backgrounds. The discussion paper outlines:
>> a brief overview of issues relevant to the development of Australia’s NPDMS
>> the background and context for the initiation of a pharmaceutical misuse strategy
>> relevant Australian and international research and data, and
>> potential areas for prevention and remediation that may be addressed through the strategy.
This paper is not intended to be a definitive coverage of issues; rather, it is intended to be thought provoking, stimulating and in some respects challenging. For a more comprehensive coverage of these issues, readers are invited to examine the full literature review.
The paper and literature review may be downloaded by clicking on the links below.
The consultation process will provide an opportunity to address such issues as whether the discussion paper and the associated literature review:
>> contain significant gaps (for example, issues, research, information, resources and examples of good practice)
>> accurately reflect the state of play
>> reflect stakeholders’ interests and concerns, and
>> contain potential responses that are consistent with stakeholders’ perspectives.
Throughout the discussion paper key questions are posed which are intended to provoke discussion in relation to the extent and nature of pharmaceutical drug misuse and potential responses. These questions appear in red.
The time frame for consultation for the development of the Strategy is as follows:
>> discussion paper released March 2011
>> a national consultation process will occur between late March and early June; and
>> written submissions will be called for mid-March to mid-May.
- The development of Australia's National Pharmaceutical Drug Misuse Strategy: A matter of balance
- Responding to pharmaceutical drug misuse problems in Australia. A Matter of Balance: A review of the literature supporting the development of Australia’s National Pharmaceutical Drug Misuse Strategy.
- A Matter of Balance: A background discussion paper to support the development of the National Pharmaceutical Drug Misuse Strategy (NPDMS)
Young Australians Alcohol Reporting System (YAARS)
Start Date: 2016
End Date: 2017
Contact Person: Dr Jane Fischer
Primary Funder: National Drug Research Institute (NDRI), Curtin University
Aim: The study aims to investigate alcohol use, outcomes of drinking, and some of the influences on alcohol use. The information from this project will be used to make recommendations on how to make things safer for young people.